On 5 October 2026, Kindstar Globalgene Technology, Inc. (Kindstar Global) repurchased 13,500 ordinary shares on the Hong Kong Stock Exchange at prices between HK$0.90 and HK$0.92, translating into a volume-weighted average cost of HK$0.9113 per share and an aggregate consideration of HK$12,302.55.

Following the transaction, issued shares outstanding (excluding treasury shares) decreased by 0.00131% to 1.03 billion, while treasury shares climbed to 9.49 million. The company’s total issued share capital remained unchanged at 1.04 billion shares because the repurchased shares are being held as treasury stock rather than cancelled.

The buyback forms part of Kindstar Global’s shareholder mandate approved on 5 June 2026, which authorises repurchases of up to 103.43 million shares. To date, the company has bought back 2.42 million shares under this mandate, representing 0.23% of the issued share count on the mandate’s approval date.

In accordance with Hong Kong listing rules, Kindstar Global is subject to a 30-day moratorium on issuing new shares or disposing of treasury shares, effective until 4 November 2026.